Ascendum Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Autoimmune disease treatment developer SetPoint Medical announced today that it raised $80 million in a preferred stock financing.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Credit: Metronom Health Chinese medical device innovation hub Dinova Medtech and US-based medical device company Metronom Health have established a joint venture to develop and sell a continuous glucose monitoring system in China.  WHY IT MATTERS Traditional fingerstick glucose meters can only provide information about intermittent glucose levels and the pain that comes with finger pricking can potentially reduce patients' adherence. By inserting a sensor into the subcutaneous tissue along with a transmitter that sends the data to a smart device, CGMs can provide continuous glucose informat...

DCP, Sequoia China lead Series B round for medical devices firm Valgen Source: Valgen Medtech May 6, 2021 Greater China-focused private equity firm DCP and tech investment bellwether Sequoia Capital China have co-led a Series B round of financing for Valgen Medtech, a developer of treatment technologies for heart diseases in China. The investment size is said to be “hundreds of millions of US dollars.” Lake Bleu Capital, a healthcare-focused asset management platform; Chinese transcatheter heart valve medical devices maker Venus Medtech; China Life Healthcare Fund, an investment vehicle o...

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform January 27, 2021 09:00 ET | Source: SetPoint Medical SetPoint Medical Valencia, California VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflammation-mediated autoimmune diseases and is i...